Pharmaceutical giant AbbVie recently urged a federal judge to rule on its suit against Louisiana’s 340B contract pharmacy law without [...] …
Month: January 2024
Q: Tell us some interesting details about your company’s history.
Imagine a world where flip phones were the pinnacle of consumer technology – that’s the era when RxStrategies was founded.
…
The top Republican on an influential Senate committee yesterday asked the nation’s two largest contract pharmacy companies for detailed information [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmakers issued a record 41 refunds to 340B covered entities in 2023. And Merck is the first to announce it [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
In the complex landscape of healthcare, the 340B program plays a vital role in ensuring that vulnerable patients with limited financial resources have access to affordable medications. It enables qualified covered entities to maximize their resources and offer a wider range of benefits and services
…
Just days prior to implementing its first contract pharmacy restrictions, Japanese pharmaceutical giant Takeda yesterday announced it will increase the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Health Resources and Services Administration (HRSA) has announced plans to host a webinar for federal grantees just days prior [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Rhode Island state lawmakers last week introduced bills that would prohibit both differentiated payments from pharmacy benefit managers (PBMs) to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Influential state senators in Kentucky, Virginia, and Florida have introduced bills recently that would prohibit drug manufacturer restrictions on 340B [...] …
